What is the most common manifestation of cardiotoxicity associated with immune checkpoint inhibitors?
•
4 min read
Myocarditis, an inflammation of the heart muscle, is the most common and most lethal cardiovascular adverse event linked to immune checkpoint inhibitor (ICI) therapy, with some estimates reporting mortality rates as high as 50%. Understanding what is the most common manifestation of cardiotoxicity associated with immune checkpoint inhibitors is critical for early detection and improving patient outcomes.
